DOI: 10.1086/431673. In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections

In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections

10.1086/431673

Crossref journal-article

Oxford University Press (OUP)

Clinical Infectious Diseases (286)

Bibliography

Bradford, P. A., WeaverâSands, D. T., & Petersen, P. J. (2005). In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and SkinâStructure Infections and Complicated IntraâAbdominal Infections. Clinical Infectious Diseases, 41(s5), S315âS332.

Authors 3

Patricia A. Bradford (first)
D. Tasha Weaver‐Sands (additional)
Peter J. Petersen (additional)

References 26 Referenced 104

10.1016/S0960-894X(99)00216-4
10.1093/jac/dkh125
10.1128/AAC.43.4.738 / Antimicrob Agents Chemother by Petersen PJ (1999)
10.1016/j.clinmicnews.2004.10.001
10.1128/AAC.45.9.2604-2608.2001
10.1016/S0924-8579(00)00198-9
10.1128/AAC.46.10.3164-3167.2002
Rose G, Loh E. Efficacy and safety of tigecycline compared with vancomycin/aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial [control no. TH-13]. In: Program and abstracts of the 11th Annual International Symposium on Staphylococci and Staphylococcal Infections (Charleston, SC). International Society on Staphylococci and Staphylococcal Infections, 2004.
Ellis-Grosse EJ, Loh E. Tigecycline compared with imipenem/cilastatin in the treatment of complicated intra-abdominal infections [poster P1317]. In: Program and abstracts of the 15th European Congress of Clinical Microbiology and Infectious Diseases (Copenhagen). Basel: European Society of Clinical Microbiology and Infectious Diseases, 2005.
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. [CLSI document M100-S15]. Vol 25. Wayne, PA: Clinical Laboratory Standards Institute, 2005.
National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. 6th ed. [NCCLS document M11-A6]. Vol 24. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 6th ed. [NCCLS document M7-A6]. Vol 23. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
10.1016/0924-8579(96)00004-0
{'key': 'rf16_188', 'first-page': '1037', 'author': 'Swartz MN', 'year': '2000', 'journal-title': 'Philadelphia: Churchill Livingstone'} / Philadelphia: Churchill Livingstone by Swartz MN (2000)
{'key': 'rf17_189', 'first-page': '821', 'author': 'Levison ME', 'year': '2000', 'journal-title': 'Philadelphia: Churchill Livingstone'} / Philadelphia: Churchill Livingstone by Levison ME (2000)
10.1128/AAC.49.3.1017-1022.2005
10.1128/AAC.47.2.665-669.2003
10.1128/AAC.49.2.791-793.2005
10.1128/AAC.47.3.972-978.2003
10.1046/j.1469-0691.2000.00034-6.x
10.1128/AAC.44.10.2747-2751.2000
10.1128/AAC.48.3.1034-1036.2004
10.1016/S0732-8893(99)00092-9
10.1128/AAC.47.1.400-404.2003
10.1016/j.diagmicrobio.2004.03.002
10.1016/j.diagmicrobio.2004.08.007

Dates

Type	When
Created	20 years, 1 month ago (Aug. 5, 2005, 8:13 a.m.)
Deposited	6 years, 5 months ago (March 12, 2019, 1:42 p.m.)
Indexed	1 year, 1 month ago (July 11, 2024, 8:40 a.m.)
Issued	20 years ago (Sept. 1, 2005)
Published	20 years ago (Sept. 1, 2005)
Published Print	20 years ago (Sept. 1, 2005)

Funders 0

None

BibTeX

@article{Bradford_2005, title={In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections}, volume={41}, ISSN={1537-6591}, url={http://dx.doi.org/10.1086/431673}, DOI={10.1086/431673}, number={s5}, journal={Clinical Infectious Diseases}, publisher={Oxford University Press (OUP)}, author={Bradford, Patricia A. and Weaver‐Sands, D. Tasha and Petersen, Peter J.}, year={2005}, month=sep, pages={S315–S332} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        7,
        11
      ]
    ],
    "date-time": "2024-07-11T12:40:22Z",
    "timestamp": 1720701622627
  },
  "reference-count": 26,
  "publisher": "Oxford University Press (OUP)",
  "issue": "s5",
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        9
      ]
    ]
  },
  "DOI": "10.1086/431673",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        8,
        5
      ]
    ],
    "date-time": "2005-08-05T12:13:16Z",
    "timestamp": 1123243996000
  },
  "page": "S315-S332",
  "source": "Crossref",
  "is-referenced-by-count": 104,
  "title": "In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin\u2010Structure Infections and Complicated Intra\u2010Abdominal Infections",
  "prefix": "10.1093",
  "volume": "41",
  "author": [
    {
      "given": "Patricia\u00a0A.",
      "family": "Bradford",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "D.\u00a0Tasha",
      "family": "Weaver\u2010Sands",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Peter\u00a0J.",
      "family": "Petersen",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "286",
  "reference": [
    {
      "key": "rf1_175",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0960-894X(99)00216-4"
    },
    {
      "key": "rf2_176",
      "doi-asserted-by": "publisher",
      "DOI": "10.1093/jac/dkh125"
    },
    {
      "key": "rf3_177",
      "doi-asserted-by": "crossref",
      "first-page": "738",
      "DOI": "10.1128/AAC.43.4.738",
      "volume": "43",
      "author": "Petersen PJ",
      "year": "1999",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "rf4_178",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/j.clinmicnews.2004.10.001"
    },
    {
      "key": "rf5_179",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.45.9.2604-2608.2001"
    },
    {
      "key": "rf6_180",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0924-8579(00)00198-9"
    },
    {
      "key": "rf7_181",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.46.10.3164-3167.2002"
    },
    {
      "key": "rf10_182",
      "unstructured": "Rose G, Loh E. Efficacy and safety of tigecycline compared with vancomycin/aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial [control no. TH-13]. In: Program and abstracts of the 11th Annual International Symposium on Staphylococci and Staphylococcal Infections (Charleston, SC). International Society on Staphylococci and Staphylococcal Infections, 2004."
    },
    {
      "key": "rf11_183",
      "unstructured": "Ellis-Grosse EJ, Loh E. Tigecycline compared with imipenem/cilastatin in the treatment of complicated intra-abdominal infections [poster P1317]. In: Program and abstracts of the 15th European Congress of Clinical Microbiology and Infectious Diseases (Copenhagen). Basel: European Society of Clinical Microbiology and Infectious Diseases, 2005."
    },
    {
      "key": "rf12_184",
      "unstructured": "Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. [CLSI document M100-S15]. Vol 25. Wayne, PA: Clinical Laboratory Standards Institute, 2005."
    },
    {
      "key": "rf13_185",
      "unstructured": "National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. 6th ed. [NCCLS document M11-A6]. Vol 24. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004."
    },
    {
      "key": "rf14_186",
      "unstructured": "National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 6th ed. [NCCLS document M7-A6]. Vol 23. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003."
    },
    {
      "key": "rf15_187",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/0924-8579(96)00004-0"
    },
    {
      "key": "rf16_188",
      "first-page": "1037",
      "author": "Swartz MN",
      "year": "2000",
      "journal-title": "Philadelphia: Churchill Livingstone"
    },
    {
      "key": "rf17_189",
      "first-page": "821",
      "author": "Levison ME",
      "year": "2000",
      "journal-title": "Philadelphia: Churchill Livingstone"
    },
    {
      "key": "rf18_190",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.49.3.1017-1022.2005"
    },
    {
      "key": "rf19_191",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.47.2.665-669.2003"
    },
    {
      "key": "rf20_192",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.49.2.791-793.2005"
    },
    {
      "key": "rf21_193",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.47.3.972-978.2003"
    },
    {
      "key": "rf22_194",
      "doi-asserted-by": "publisher",
      "DOI": "10.1046/j.1469-0691.2000.00034-6.x"
    },
    {
      "key": "rf23_195",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.44.10.2747-2751.2000"
    },
    {
      "key": "rf24_196",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.48.3.1034-1036.2004"
    },
    {
      "key": "rf25_197",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0732-8893(99)00092-9"
    },
    {
      "key": "rf26_198",
      "doi-asserted-by": "publisher",
      "DOI": "10.1128/AAC.47.1.400-404.2003"
    },
    {
      "key": "rf27_199",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/j.diagmicrobio.2004.03.002"
    },
    {
      "key": "rf28_200",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/j.diagmicrobio.2004.08.007"
    }
  ],
  "container-title": "Clinical Infectious Diseases",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://academic.oup.com/cid/article-pdf/41/Supplement_5/S315/815598/41-Supplement_5-S315.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        3,
        12
      ]
    ],
    "date-time": "2019-03-12T17:42:37Z",
    "timestamp": 1552412557000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://academic.oup.com/cid/article-lookup/doi/10.1086/431673"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005,
        9
      ]
    ]
  },
  "references-count": 26,
  "journal-issue": {
    "issue": "s5",
    "published-print": {
      "date-parts": [
        [
          2005,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "10.1086/431673"
  ],
  "URL": "http://dx.doi.org/10.1086/431673",
  "relation": {},
  "ISSN": [
    "1058-4838",
    "1537-6591"
  ],
  "subject": [],
  "container-title-short": "CLIN INFECT DIS",
  "published": {
    "date-parts": [
      [
        2005,
        9
      ]
    ]
  }
}